… Takayasu arteritis and Takayasu’s arteritis were searched in combination with the following
key words: treatment… was discontinued in 15 patients and was successfully tapered to <10 mg…

… Sixty percent of our patients treated with glucocorticoids alone responded at least once. …
with cyclophosphamide in the treatment of patients with Takayasu arteritis and has substantially …

Takayasu arteritis (TA) is a chronic nonspecific granulomatous vasculitis affecting aorta and
its main branches, coronary and pulmonary arteries. TA often occurs in young women and …

Takayasu arteritis (TAK) is a challenging chronic, granulomatous, large-vessel systemic
vasculitis, mostly due to difficulties in early diagnosis and assessing actual disease activity. …

… of large vessel vasculitis: can we separate giant cell arteritis from Takayasu arteritis? … There
are also attempts to improve the success of endovascular interventions in TAK by using new …

Takayasu arteritis (TA) is a form of idiopathic large vessel vasculitis that predominantly
affects women of reproductive age. Although TA is a rare disease, the interpretation of …

… patients with GCA, 2 and pathological changes of extensive arteritis with giant cells in both
GCA and Takayasu arteritis, 3 we treated our patient with intravenous acyclovir, 15 mg/kg 3 …

… A (SAA), and cytokine profiles in the serum of a Takayasu arteritis patient during tocilizumab
treatment. The treatment improved the WBC, CRP, fibrinogen, and SAA levels and reduced …

… Takayasu arteritis. Still today, large areas of TA pathogenesis and disease-activity assessment
need to be further investigated to better treat … plasmablasts were successfully treated with …

… with Takayasu's arteritis were followed prospectively for an average of 4.6 years. Sixteen
patients with active inflammatory Takayasu's arteritis were treated … surgery was successful in 7 …